Belgium

The European Commission has approved Belgium company UCB's intravenous (iv) formulation of Keppra (levetiracetam) for the treatment of partial-onset seizures.

India's Ranbaxy has acquired Ethimed - the tenth largest generics firm in Belgium - as part of its European expansion plan. No financial details were released but the deal was described... 2006-03-31